Search Results - "HILLE, D. A"

In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: The LIFE Study by Okin, P. M., Hille, D. A., Wiik, B. P., Kjeldsen, S. E., Lindholm, L. H., Dahlöf, B., Devereux, R. B.

“…Aims Although hypertensive patients with low baseline HDL cholesterol levels have a higher incidence of diabetes mellitus, whether changing levels of HDL over…”
Get full text

The effect of baseline physical activity on cardiovascular outcomes and new‐onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study by Fossum, E., Gleim, G. W., Kjeldsen, S. E., Kizer, J. R., Julius, S., Devereux, R. B., Brady, W. E., Hille, D. A., Lyle, P. A., Dahlöf, B.

“… Objectives.  Physical activity (PA) is a preventive strategy for cardiovascular disease and for managing cardiovascular risk factors. There is little…”
Get full text

Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study by DE SIMONE, G, OLSEN, M. H, WACHTELL, K, HILLE, D. A, DAHLÖF, B, IBSEN, H, KJELDSEN, S. E, LYLE, P. A, DEVEREUX, R. B

“…The relation of metabolic syndrome (MetS) with cardiovascular outcome may be less evident when preclinical cardiovascular disease is present. We explored, in a…”
Get full text

Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial Infarction: Results From a Randomized Trial by Morrow, David A, Cannon, Christopher P, Rifai, Nader, Frey, Martin J, Vicari, Ralph, Lakkis, Nasser, Robertson, Debbie H, Hille, Darcy A, DeLucca, Paul T, DiBattiste, Peter M, Demopoulos, Laura A, Weintraub, William S, Braunwald, Eugene, for the TACTICS-TIMI 18 Investigators

“…CONTEXT Cardiac troponins I (cTnI) and T (cTnT) are useful for assessing prognosis in patients with unstable angina and non–ST-segment elevation myocardial…”
Get full text

Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients by Okin, Peter M., Hille, Darcy A., Kjeldsen, Sverre E., Lindholm, Lars H., Edelman, Jonathan M., Dahlöf, Björn, Devereux, Richard B.

“…Background Treatment of hypertensive patients with a losartan-based regimen was associated with greater regression of electrocardiographic (ECG) left…”
Get full text

Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study by de Simone, G, Okin, P.M, Gerdts, E, Olsen, M.H, Wachtell, K, Hille, D.A, Dahlöf, B, Kjeldsen, S.E, Devereux, R.B

“…Abstract Background and aims Clusters of metabolic abnormalities resembling phenotypes of metabolic syndrome predicted outcome in the LIFE study, independently…”
Get full text

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy : The LIFE (losartan intervention for endpoint reduction in hypertension) study by DE SIMONE, Giovanni, WACHTELL, Kristian, KJELDSEN, Sverre E, LEDERBALLE-PEDERSEN, Ole, LINDHOLM, Lars H, NIEMINEN, Markku S, OMVIK, Per, OPARIL, Suzanne, DEVEREUX, Richard B, PALMIERI, Vittorio, HILLE, Darcy A, BEEVERS, Gareth, DAHLOF, Bjorn, DE FAIRE, Ulf, FYHRQUIST, Frej, IBSEN, Hans, JULIUS, Stevo

“…Obesity may independently increase the risk of adverse events in hypertension with target-organ damage. We investigated whether body build was independently…”
Get full text

Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy by Fyhrquist, Frej, Dahlöf, Björn, Devereux, Richard B, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Hille, Darcy A, Lyle, Paulette A, Edelman, Jonathan M, Snapinn, Steven M, Wedel, Hans

“…In the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study, the primary composite end point of cardiovascular death, stroke, and…”
Get full text

Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy by Devereux, Richard B., de Faire, Ulf, Fyhrquist, Frej, Harris, Katherine E., Ibsen, Hans, Kjeldsen, Sverre E., Lederballe-Pedersen, Ole, Lindholm, Lars H., Nieminen, Markku S., Omvik, Per, Oparil, Suzanne, Wedel, Hans, Hille, Darcy A., Dahlöf, Björn

“…ABSTRACT Objective: To compare blood pressure response and antihypertensive medication use visit-by-visit from baseline in patients receiving losartan-based or…”
Get full text

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study by Kjeldsen, Sverre E, Devereux, Richard B, Hille, Darcy A, Lyle, Paulette A, Dahlöf, Björn, Julius, Stevo, Edelman, Jonathan M, Snapinn, Steven M, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans

“…We assessed readily available patient characteristics, including albuminuria (not included in traditional cardiovascular risk scores), as predictors of…”
Get more information

All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy by Okin, Peter M., Kjeldsen, Sverre E., Julius, Stevo, Hille, Darcy A., Dahlöf, Björn, Edelman, Jonathan M., Devereux, Richard B.

“…Background Although higher heart rate (HR) at baseline has been associated with an increased risk of cardiovascular (CV) and all-cause mortality, the…”
Get full text

Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension by Okin, Peter M, Wachtell, Kristian, Devereux, Richard B, Harris, Katherine E, Jern, Sverker, Kjeldsen, Sverre E, Julius, Stevo, Lindholm, Lars H, Nieminen, Markku S, Edelman, Jonathan M, Hille, Darcy A, Dahlöf, Björn

“…CONTEXT Atrial fibrillation (AF) is associated with increased risk of mortality and cardiovascular events, particularly stroke, making prevention of new-onset…”
Get full text

Effect of Hemoglobin Levels on Cardiovascular Outcomes in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy (from the LIFE Study) by Smebye, Marianne L, Iversen, Emil K, Høieggen, Aud, MD, PhD, Flaa, Arnljot, MD, Os, Ingrid, MD, PhD, Kjeldsen, Sverre E., MD, PhD, Olsen, Michael Hecht, MD, PhD, Chattopadhyay, Arghya, PhD, Hille, Darcy A., MS, EMBA, Lyle, Paulette A., BS, Devereux, Richard B., MD, PhD, Dahlöf, Björn, MD, PhD

“…The optimal hemoglobin level in patients with hypertension or heart failure is not yet defined. The aim of the present investigation was to examine the…”
Get full text

Continuum of renoprotection with Losartan at all stages of type 2 diabetic nephropathy: A post Hoc analysis of the RENAAL trial results by REMUZZI, Giuseppe, RUGGENENTI, Piero, PERNA, Annalisa, DIMITROV, Borislav D, DE ZEEUW, Dick, HILLE, Darcy A, SHAHINFAR, Shahnaz, CARIDES, George W, BRENNER, Barry M

“…Renin angiotensin system inhibitor therapy is seldom offered to individuals who have diabetes and advanced chronic kidney disease because of safety concerns…”
Get full text

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study by Nordestgaard, Børge G, Kontula, Kimmo, Benn, Marianne, Dahlöf, Björn, de Faire, Ulf, Edelman, Jonathan M, Eliasson, Erik, Fyhrquist, Frej, Hille, Darcy A, Ibsen, Hans, Lyle, Paulette A, Berg, Kåre, Sandberg, Mia, Sethi, Amar A, Wong, Peggy H, Os, Ingrid

“…OBJECTIVEThis pharmacogenetics substudy from the Losartan Intervention for Endpoint reduction in Hypertension study in patients with hypertension and left…”
Get full text

Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study by APPEL, Gerald B, RADHAKRISHNAN, Jai, BRENNER, Barry M, AVRAM, Morrell M, DEFRONZO, Ralph A, ESCOBAR-JIMENEZ, Fernando, CAMPOS, M. M, BURGESS, Ellen, HILLE, Darcy A, DICKSON, Tania Z, SHAHINFAR, Shahnaz

“…Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study Gerald B. Appel , MD 1 , Jai Radhakrishnan , MD 1 , Morrell M. Avram , MD 2 , Ralph…”
Get full text

Body build and risk of cardiovascular events in hypertension:: The life study by de Simone, G, Wachtell, K, Palmieri, V, Beevers, G, Dahlof, B, de Faire, U, Fyhrquist, F, Ibsen, H, Kjeldsen, SE, Lederballe-Pedersen, O, Lindholm, LH, Nieminen, MS, Omvik, R, Oparil, S, Hille, DA

Get full text

Body build and risk of cardiovascular events in hypertension: The LIFE Study by de Simone, G, Wachtel, K, Palmieri, V, Beavers, G, Dahlof, B, de Faire, U, Fyhrquist, F, Ibsen, H, Kjeldsen, SE, Lederballe-Pedersen, O, Lindholm, LH, Nieminen, MS, Omvik, P, Oparil, S, Hille, DA, Devereux, RB

Get full text